Scientific Publication: Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system.

We are proud to announce our most recent scientific publication:

FREYER, N., KNÖSPEL, F., DAMM, G., GREUEL, S., SCHNEIDER, C., SEEHOFER, D., STÖHR, T., PETERSEN, K. U., & ZEILINGER, K. (2019). Metabolism of remimazolam in primary human hepatocytes during continuous long-term infusion in a 3-D bioreactor system. Drug design, development and therapy, 13, 1033–1047. https://doi.org/10.2147/DDDT.S186759

Previous
Previous

Scientific Publication: Online measurement of oxygen enables continuous noninvasive evaluation of human-induced pluripotent stem cell (hiPSC) culture in a perfused 3D hollow-fiber bioreactor.

Next
Next

Scientific Publication: Microscale 3D Liver Bioreactor for In Vitro Hepatotoxicity Testing under Perfusion Conditions.